eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Urinary Tract Infection

Author: Stanley Hellerstein, MD, Pediatric Nephrologist, Children's Mercy Hospital of Kansas City; Ernest L Glasscock, MD Chair in Pediatric Research, Professor of Pediatrics, University of Missouri School of Medicine at Kansas City
Contributor Information and Disclosures

Updated: Nov 23, 2009

Introduction

Background

Urinary tract infection (UTI) is one of the most common infections of childhood. It distresses the child, concerns the parents, and may cause permanent kidney damage.

In some instances, urinary tract infection results in recognition of an important underlying structural or neurogenic abnormality of the urinary tract. The febrile infant or child with clinically significant bacteriuria and no other site of infection to explain the fever, even in the absence of systemic symptoms, has pyelonephritis (ie, upper urinary tract infection). The graph below details a reasonable approach for febrile infants younger than 3 months with a temperature of more than 38 º C.

Application of low-risk criteria and approach for...

Application of low-risk criteria and approach for the febrile infant: A reasonable approach for treating febrile infants younger than 3 months who have a temperature of greater than 38°C.

Application of low-risk criteria and approach for...

Application of low-risk criteria and approach for the febrile infant: A reasonable approach for treating febrile infants younger than 3 months who have a temperature of greater than 38°C.


Children with urinary tract infections and voiding symptoms, little or no fever, and no systemic symptoms have lower urinary tract infections (cystitis).

The site of infection is often unclear when a child with pyuria and clinically significant bacteriuria has another potential source of fever (eg, otitis media, pharyngitis). When urinary tract infection is diagnosed in a child, an attempt should be made to identify any risk factors for the urinary tract infection (eg, anatomic anomaly, voiding dysfunction, constipation).

Pathophysiology

Almost all urinary tract infections are ascending in origin. Disturbance of the normal periurethral flora, which is part of the host defense against colonization by pathogenic bacteria, predisposes a person to a urinary tract infection. Bacteria of the periurethral flora also inhabit the distal urethra. Urine in the proximal urethra, urinary bladder, and other proximal sites in the urinary tract is normally sterile. Uropathogens must gain access to the urinary bladder and proliferate for infection to occur. Uropathogens in the distal urethra may gain access to the bladder because of turbulent urine flow during normal voiding or because of dysfunctional voiding. Successful urinary bladder colonization is unlikely unless bladder defense mechanisms are impaired because normal voiding usually results in an essentially complete washout of contaminating bacteria.

After birth, the periurethral area, including the distal urethra, becomes colonized with aerobic and anaerobic microorganisms that appear to function as a defense barrier against colonization by uropathogens. In early childhood, enterobacteria and enterococci are part of the normal periurethral flora. Escherichia coli is the dominant gram-negative species in young girls, whereas E coli and Proteus species predominate in boys. Children as old as about 5 years are predisposed to have urinary tract infections, partly because of periurethral colonization by E coli, enterococci, and Proteus species. These potential uropathogens usually diminish in the first year of life and are rarely found in children older than 5 years. Studies of girls and women prone to urinary tract infection showed that periurethral colonization occurs with the specific bacterium that causes the next infection.

Frequency

International

Studies from Sweden have indicated that at least 3% of girls and 1% of boys have a symptomatic urinary tract infection by the age of 11 years. However, data from recent epidemiologic surveys suggest incidences higher than these. Occurrences of a first-time symptomatic urinary tract infection are highest for both boys and girls during the first year of life and markedly decrease after that. The minimum cumulative incidence in both boys and girls aged 2 years is slightly over 2%. Most episodes of urinary tract infection during the first year of life are pyelonephritis. After 2 years of age first-time urinary tract infection manifesting as cystitis is common among girls. More recent data suggest that 8% of girls have a symptomatic urinary tract infection during childhood. The incidence of a first urinary tract infection in boys older than 2 years is exceedingly low, probably less than 0.5%.

Mortality/Morbidity

Mortality related to urinary tract infection is exceedingly rare for otherwise healthy children in developed countries.

Morbidity associated with pyelonephritis is characterized by systemic symptoms, such as fever, abdominal pain, vomiting, and dehydration. Bacteremia and clinical sepsis may occur. Children with pyelonephritis also may have cystitis. Long-term complications of pyelonephritis are hypertension, impaired kidney function, end-stage renal disease (ESRD), and complications of pregnancy (eg, urinary tract infection, pregnancy-related hypertension, low-birth-weight neonates).

The voiding symptoms of cystitis are usually transient, clearing within 24-48 hours of effective treatment. Long-term complications of urinary tract infection are caused by renal damage secondary to pyelonephritis. Cystitis may cause voiding symptoms and require antibiotics, but it is not associated with long-term deleterious kidney damage.

Race

Data are scant. However, in studies by Hoberman et al, the prevalence of a febrile urinary tract infection in white infants exceeded that of black infants.1 These investigators found that 17% of white female infants younger than 1 year with a temperature of 39°C or more seen in an emergency department had urinary tract infections.

Sex

During the first few months of life, the incidence of urinary tract infection in boys exceeds that in girls. By the end of the first year and thereafter, both first-time and recurrent urinary tract infections are most common in girls. The prevalence of urinary tract infection in girls aged between 1 and 2 years is 8.1%; in boys, it is 1.9%. The rate in circumcised boys is low, 0.2-0.4%. The rate in uncircumcised boys is 5-20 times higher than in circumcised boys.

In a systematic review, investigators calculated crude estimates of urinary tract infection during the first 24 months of life.2 Rates were 3% in boys younger than 1 year, 2% in boys older than 1 year, 7% in girls younger than 1 year, and 8% in girls aged 1-2 years.

Age

First-time urinary tract infection is most common in the first 2 years of life.

Clinical

History

The 2 broad clinical categories of urinary tract infection (UTI) are pyelonephritis, or upper urinary tract infection, and cystitis, or lower urinary tract infection. The history and clinical course varies with the patient's age and the specific diagnosis.

  • Children aged 0-2 months: Neonates and infants in this age range who have pyelonephritis usually do not have symptoms localized to the urinary tract. Urinary tract infection is discovered as part of an evaluation for neonatal sepsis.
  • Infants and children aged 2 months to 2 years
    • Infants and young children in this age range with pyelonephritis may have a history of unexplained fever (eg, rectal or tympanic membrane–derived temperature of >38°C).
    • These patients are at higher risk for renal injury than are older children, possibly because the lack of localizing signs of infection delays the start of antibiotic therapy. This situation had led to a 3-day rule: An infant or child with unexplained fever should not be observed for more than 3 days without a urine specimen being obtained.
    • Some infants with pyelonephritis in this age range have fever and few other symptoms, whereas others are acutely ill and have a history of irritability, decreased oral intake, abdominal pain, vomiting, and loose bowel movements.
    • Children aged 1-2 years may present with voiding symptoms suggestive of cystitis, with crying on urination or only a foul odor to the urine in the absence of clinically significant fever (temperature <38°C).
  • Children aged 2-6 years
    • Children in this age group with febrile urinary tract infection (pyelonephritis) usually have systemic symptoms with loss of appetite; irritability; and abdominal, flank, or back pain. Voiding symptoms may be present or absent.
    • Children with acute cystitis have voiding symptoms with little or no temperature elevation. Voiding dysfunction may include urgency, frequency, hesitancy, dysuria, or urinary incontinence.
    • Suprapubic or abdominal pain may be present, and the urine sometimes has a strong or foul odor.
  • Children older than 6 years and adolescents
    • Urinary tract infection among children in this age range usually affects the lower tract, but pyelonephritis also occurs. Symptoms are similar to those in children aged 2-6 years.
    • Girls who have pyelonephritis in infancy or early childhood, including those with persistence of vesicoureteric reflux (VUR), usually have cystitis with urinary tract infection when they are older. They are also prone to have a recurrence during pregnancy.

Physical

  • Findings on physical examination, such as tenderness in the costovertebral angle or flank, may help localize the site of infection to the kidney. Suprapubic tenderness may be present.
  • Infants and younger children with pyelonephritis usually have no localizing findings, but they are febrile and irritable.
  • The older children with pyelonephritis often have tenderness of the flank or costovertebral angle, and those with cystitis may have suprapubic tenderness.

Causes

Proliferation of bacteria in the urinary tract is the cause of urinary tract infection.

  • Infections are almost always ascending in origin and caused by bacteria in the periurethral flora and the distal urethra. These bacteria inhabit the distal GI tract and colonize the perineal area. E coli usually causes a child's first infection, but other gram-negative bacilli and enterococci may also cause infection.
  • Staphylococcal infections, especially those due to Staphylococcus saprophyticus, are common causes of urinary tract infection among female adolescents.
  • Entry of bacteria into the urinary bladder may be the result of turbulent flow during normal voiding, voiding dysfunction, or catheterization. In addition, sexual intercourse or genital manipulation may foster the entry of bacteria into the urinary bladder. More rarely, the urinary tract may be colonized during systemic bacteremia (sepsis); this usually happens in infancy.
  • Risk factors for urinary tract infection include the following:
    • Children who receive broad-spectrum antibiotics (eg, amoxicillin, cephalexin) that are likely to alter GI and periurethral flora are at increased risk for urinary tract infection because these drugs disturb the natural defense against colonization by pathogenic bacteria.
    • Prolonged incubation of bacteria in bladder urine due to incomplete bladder emptying or infrequent voiding compromises an important bladder defense against infection. Symptoms of voiding dysfunction, such as urgency, frequency, hesitancy, dribbling, or incontinence may occur in the absence of infection or local irritation because of uninhibited detrusor contractions. When the child attempts to prevent incontinence during a detrusor contraction by posturing (eg, obstructing the urethra), bacteria-laden urine in the distal urethra may be milked back into the urinary bladder (urethrovesical reflux). This mode of bacterial access is a common risk factor for urinary tract infection among pediatric patients who use posturing or pelvic withholding procedures to prevent incontinence.
    • Voiding dysfunction is not usually encountered in a child without neurogenic or anatomic abnormality of the bladder until the child is in the process of achieving daytime urinary control. Children with voiding dysfunction may attempt to prevent incontinence during an uninhibited detrusor contraction by voluntarily increasing outlet resistance. This may be achieved by using various posturing maneuvers, such as tightening of the pelvic-floor muscles, applying direct pressure to the urethra with the hands, or performing the Vincent curtsy, which consists squatting on the floor and pressing the heel of one foot against the urethra.
    • Constipation, with the rectum chronically dilated by feces, is an important cause of voiding dysfunction. Neurogenic or anatomic abnormalities of the urinary bladder may also cause voiding dysfunction.
    • Neonatal circumcision decreases the risk of urinary tract infection by about 90% in male infants during the first year of life. The risk of urinary tract infection in a circumcised infant is about 1 in 1000 during the first year, whereas an uncircumcised male infant has a 1 in 100 risk of developing a urinary tract infection. Given this risk, 111 healthy male infants must be circumcised to prevent 1 urinary tract infection. The risk and long-term effect of scarring due to 1 preventable urinary tract infection in a male infant are not known.

More on Urinary Tract Infection

Overview: Urinary Tract Infection
Differential Diagnoses & Workup: Urinary Tract Infection
Treatment & Medication: Urinary Tract Infection
Follow-up: Urinary Tract Infection
Multimedia: Urinary Tract Infection
References

References

  1. Hoberman A, Chao HP, Keller DM, et al. Prevalence of urinary tract infection in febrile infants. J Pediatr. Jul 1993;123(1):17-23. [Medline].

  2. Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics. Apr 1999;103(4):e54. [Medline][Full Text].

  3. Girardet P, Frutiger P, Lang R. Urinary tract infections in pediatric practice. A comparative study of three diagnostic tools: dip-slides, bacterioscopy and leucocyturia. Paediatrician. 1980;9(5-6):322-37. [Medline].

  4. Goldsmith BM, Campos JM. Comparison of urine dipstick, microscopy, and culture for the detection of bacteriuria in children. Clin Pediatr (Phila). Apr 1990;29(4):214-8. [Medline].

  5. Anderson JD, Chambers GK, Johnson HW. Application of a leukocyte and nitrite urine test strip to the management of children with neurogenic bladder. Diagn Microbiol Infect Dis. Jul 1993;17(1):29-33. [Medline].

  6. Craver RD, Abermanis JG. Dipstick only urinalysis screen for the pediatric emergency room. Pediatr Nephrol. Jun 1997;11(3):331-3. [Medline].

  7. Shaw KN, McGowan KL, Gorelick MH, Schwartz JS. Screening for urinary tract infection in infants in the emergency department: which test is best?. Pediatrics. Jun 1998;101(6):E1. [Medline].

  8. Anad FY. A simple method for selecting urine samples that need culturing. Ann Saudi Med. Jan-Mar 2001;21(1-2):104-5. [Medline].

  9. Bachur R, Harper MB. Reliability of the urinalysis for predicting urinary tract infections in young febrile children. Arch Pediatr Adolesc Med. Jan 2001;155(1):60-5. [Medline].

  10. Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. Jul 1999;104(1 Pt 1):79-86. [Medline].

  11. Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L. Cranberry juice for the prevention of recurrent urinary tract infections: A randomized controlled trial in children. Scand J Urol Nephrol. 2009;43(5):369-372. [Medline].

  12. AAP Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial UTI in febrile infants and young children. AAP. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics. Apr 1999;103(4 Pt 1):843-52. [Medline].

  13. Alon US. Optimal timing of follow-up voiding cystourethrogram in children with vesicoureteral reflux. Am J Urol Rev. 2005;3:472-8.

  14. Alon US, Ganapathy S. Should renal ultrasonography be done routinely in children with first urinary tract infection?. Clin Pediatr (Phila). Jan 1999;38(1):21-5. [Medline].

  15. Ataei N, Madani A, Habibi R, Khorasani M. Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years. Pediatr Nephrol. 2005;20:1439-44. [Medline].

  16. Bergstrom T, Lincoln K, Redin B, Winberg J. Studies of urinary tract infections in infancy and childhood. X. Short or long-term treatment in girls with first or second-time urinary tract infections uncomplicated by obstructive urological abnormalities. Acta Paediatr Scand. May 1968;57(3):186-94. [Medline].

  17. Bloomfield P, Hodson EM, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. Jan 25 2005;(1):CD003772. [Medline].

  18. Chandra M. Voiding and its disorders in children. In: Monographs in Clinical Pediatrics. Vol 10. Amsterdam, the Netherlands: Harwood Academic; 1998:217-29.

  19. [Guideline] Cohen AL, Rivara FP, Davis R, Christakis DA. Compliance with guidelines for the medical care of first urinary tract infectionsin infants: a population-based study. Pediatrics. Jun 2005;115(6):1474-8. [Medline].

  20. Craig JC, Knight JF, Sureshkumar P, et al. Effect of circumcision on incidence of urinary tract infection in preschool boys. J Pediatr. Jan 1996;128(1):23-7. [Medline].

  21. Dick PT, Feldman W. Routine diagnostic imaging for childhood urinary tract infections: a systematic overview. DIALYSIS. Jan 1996;128(1):15-22. [Medline].

  22. Giorgi LJ, Bratslavsky G, Kogan BA. Febrile urinary tract infections in infants: renal ultrasound remains necessary. J Urol. Feb 2005;173(2):568-70. [Medline].

  23. Hansson S, Dhamey M, Sigstrom O, et al. Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol. 2004;172:1071-4.

  24. Hellerstein S. Urinary tract infections in children with specific consideration of voiding dysfunction. In: Monographs in Clinical Pediatrics. Vol 10. Amsterdam, the Netherlands: Harwood Academic; 1998:183-97.

  25. Hellerstein S. Diagnosis of infections of the urinary tract. In: Urinary Tract Infections in Children. Chicago, IL: Year Book Medical; 1982:1-14.

  26. Hellerstein S. Urinary tract infections. Old and new concepts. Pediatr Clin North Am. Dec 1995;42(6):1433-57. [Medline].

  27. Hellerstein S. Why do children have UTIs and what can we do about them?. Dialog Pediatr Urol. 1998;21:1-8.

  28. Hoberman A, Charron M, Hickey RW, et al. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med. 2003;348:195-202. [Medline].

  29. Hoberman A, Wald ER. Urinary tract infections in young febrile children. Pediatr Infect Dis J. Jan 1997;16(1):11-7. [Medline].

  30. Jahnukainen T, Chen M, Celsi G. Mechanisms of renal damage owing to infection. Pediatr Nephrol. 2005;20:1043-53. [Medline].

  31. Jakobsson B, Esbjorner E, Hansson S. Minimum incidence and diagnostic rate of first urinary tract infection. Pediatrics. Aug 1999;104(2 Pt 1):222-6. [Medline].

  32. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. Aug 1997;100(2 Pt 1):228-32. [Medline].

  33. Lu KC, Chen PY, Huang FL, et al. Is combination antimicrobial therapy required for urinary tract infection in children?. J Microbiol Immunol Infect. Mar 2003;36(1):56-60. [Medline].

  34. Malone PS. Circumcision for preventing urinary tract infection in boys: European view. Arch Dis Child. 2005;90:773-4. [Medline].

  35. Marild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr. May 1998;87(5):549-52. [Medline].

  36. Michael M, Hodson EM, Craig JC, et al. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev. 2003;(1):CD003966. [Medline].

  37. Moorthy I, Easty M, McHugh K, et al. The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection. Arch Dis Child. 2005;90:733-6. [Medline].

  38. Moorthy I, Wheat D, Gordon I. Ultrasonography in the evaluation of renal scarring using DMSA scan as the gold standard. Pediatr Nephrol. 2004;19:153-6. [Medline].

  39. Rushton HG. Commentary on clinical relevance of 99mTc-DMSA scintigraphy. J Urol. 1994;152:1068-9.

  40. Schoen EJ. Circumcision for preventing urinary tract infections in boys: North American view. Arch Dis Child. 2005;90:772-3. [Medline].

  41. Schoen EJ. The foreskin and urinary tract infections. J Pediatr. Oct 1989;115(4):663-4. [Medline].

  42. Shaw KN, Gorelick M, McGowan KL, et al. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics. Aug 1998;102(2):e16. [Medline].

  43. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys:a systematic review of randomised trials and observational studies. Arch Dis Child. 2005;90:853-8. [Medline].

  44. Sreenarasimhaiah S, Hellerstein S. Urinary tract infections per se do not cause end-stage kidney disease. Pediatr Nephrol. Apr 1998;12(3):210-3. [Medline].

  45. Stark H. Urinary tract infections in girls: the cost-effectiveness of currently recommended investigative routines. Pediatr Nephrol. Apr 1997;11(2):174-7; discussion 180-1. [Medline].

  46. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 9th ed. Cleveland, OH: Lexi-Comp Inc.; 2002-2003.

  47. Wiswell TE, Roscelli JD. Corroborative evidence for the decreased incidence of urinary tract infections in circumcised male infants. Pediatrics. Jul 1986;78(1):96-9. [Medline].

  48. Zamir G, Sakran W, Horowitz Y, et al. Urinary tract infection: is there a need for routine renal ultrasonography?. Arch Dis Child. 2004;89:466-8. [Medline].

Further Reading

Keywords

urinary tract infection, UTI, cystitis, pyelonephritis, urethritis, urinary tract abnormality, bacteriuria, upper urinary tract infection, lower tract urinary infection, pyuria, uropathogens, periurethral colonization, treatment, diagnosis

Contributor Information and Disclosures

Author

Stanley Hellerstein, MD, Pediatric Nephrologist, Children's Mercy Hospital of Kansas City; Ernest L Glasscock, MD Chair in Pediatric Research, Professor of Pediatrics, University of Missouri School of Medicine at Kansas City
Stanley Hellerstein, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, and American Society of Pediatric Nephrology
Disclosure: Nothing to disclose.

Medical Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; sanofi pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Leslie L Barton, MD, Professor, Program Director, Department of Pediatrics, University of Arizona School of Medicine
Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.